A PILOT TRIAL OF GEMCITABINE IN COMBINATION WITH CAPECITABINE OR ERLOTINIB COMPARED TO GEMCITABINE ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Cho, J. Y. [1 ]
Lim, J. Y. [1 ]
Lee, S. J. [1 ]
Lee, D. K. [1 ]
Park, J. S. [1 ]
Yoon, D. S. [1 ]
Min, Y. H. [2 ]
机构：
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea
[2] Severance Hosp, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Byeong-Bae Park
    Joon Oh Park
    Hyo Rak Lee
    Jeeyun Lee
    Dong Wook Choi
    Seong-Ho Choi
    Jin Seok Heo
    Jong Kyun Lee
    Kyu Taek Lee
    Do Hoon Lim
    Young Suk Park
    Ho-Yeong Lim
    Won Ki Kang
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 489 - 494
  • [42] Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
    Herrmann, Richard
    Bodoky, Gyoergy
    Ruhstaller, Thomas
    Glimelius, Bengt
    Bajetta, Emilio
    Schueller, Johannes
    Saletti, Piercarlo
    Bauer, Jean
    Figer, Arie
    Pestalozzi, Bernhard
    Koehne, Claus-Henning
    Mingrone, Walter
    Stemmer, Salomon M.
    Tamas, Karin
    Kornek, Gabriela V.
    Koeberle, Dieter
    Cina, Susanne
    Bernhard, Juerg
    Dietrich, Daniel
    Scheithauer, Werner
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2212 - 2217
  • [43] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Park, Byeong-Bae
    Park, Joon Oh
    Lee, Hyo Rak
    Lee, Jeeyun
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho-Yeong
    Kang, Won Ki
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 489 - 494
  • [44] Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer
    Jeon, Eun Kyoung
    Won, Hye-Sung
    Ko, Yoon-Ho
    Lee, In Seok
    Hong, Tae Ho
    You, Young Kyoung
    Lee, Myung Ah
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) : 1625 - 1630
  • [45] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Shui-Fang Jin
    Zhao-Kun Fan
    Lei Pan
    Li-Ming Jin
    Hepatobiliary & Pancreatic Diseases International, 2017, 16 (03) : 236 - 244
  • [46] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Jin, Shui-Fang
    Fan, Zhao-Kun
    Pan, Lei
    Jin, Li-Ming
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 236 - 244
  • [47] Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
    Eileen M O'Reilly
    Ghassan K Abou-Alfa
    Nature Clinical Practice Oncology, 2008, 5 : 312 - 313
  • [48] Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
    Van Cutsem, E
    de Velde, HV
    Karasek, P
    Oettle, H
    Vervenne, WL
    Szawlowski, A
    Schoffski, P
    Post, S
    Verslype, C
    Neumann, H
    Safran, H
    Humblet, Y
    Ruixo, JP
    Ma, Y
    Von Hoff, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1430 - 1438
  • [49] Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
    O'Reilly, E. M.
    Abou-Alfa, G. K.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (06): : 312 - 313
  • [50] Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
    Loehr, J. M.
    Haas, S. L.
    Bechstein, W. -O.
    Bodoky, G.
    Cwiertka, K.
    Fischbach, W.
    Foelsch, U. R.
    Jaeger, D.
    Osinsky, D.
    Prausova, J.
    Schmidt, W. E.
    Lutz, M. P.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1214 - 1222
12345